Literature DB >> 31069419

[Ethical consideration of studies involving human subjects outside the regulatory framework: not mandatory, but of high relevance].

Iris Pigeot1,2, Ronja Foraita3, Cornelia Frömke4, Bernhard Haller5, Verena Sophia Hoffmann6, Antonia Zapf7.   

Abstract

According to the Declaration of Helsinki, ethics committees are obliged to evaluate any type of medical research involving human subjects in order to ensure an objective view on ethical considerations. This does not only mean considering whether the risks to study participants are ethically justifiable or not, but also checking whether the scientific quality of a study is sufficient. However, the role of ethics committees differs depending on whether the study to be considered is, for example, an approval study according to the German Medicines Act (AMG) or whether the study is outside the regulatory framework. For these so-called unregulated studies it is not always mandatory to obtain approval from an ethics committee or an institutional review board.In this paper, we first explain the term "unregulated studies" in detail and elaborate for which types of unregulated studies an application for ethical approval is required before we deal with the application for ethical approval as such and in particular with the study protocol as one of its major components. Registry studies, postmarketing surveillance studies, analyses of secondary data, surveys, intervention, and prognostic studies serve as examples to illustrate the broad range of unregulated studies.Finally, we discuss crucial aspects of the role of ethics committees with respect to the consideration of unregulated studies. In our conclusion, we point out the necessity of having ethics committees at each university in Germany that are also responsible for unregulated studies. In addition, the German legislature should define a stricter regulation such that unregulated studies also have to adhere to the vote of the ethics committee.

Entities:  

Keywords:  Biometrical aspects; Ethical approval; Ethics committee; Study protocol; Unregulated studies

Mesh:

Year:  2019        PMID: 31069419     DOI: 10.1007/s00103-019-02947-5

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  1 in total

1.  Comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocols.

Authors:  Geraldine Rauch; Lorena Hafermann; Ulrich Mansmann; Iris Pigeot
Journal:  BMJ Open       Date:  2020-02-04       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.